Erlotinib Terminated Phase 1 Trials for Stage IV Non-Small Cell Lung Cancer / Non-small Cell Lung Cancer (NSCLC), Recurrent / Non-Small Cell Lung Cancer Recurrent / Non-small Cell Lung Cancer (NSCLC), Stage IV Treatment